Table 1 Baseline characteristics and previous adverse pregnancy history of 115 pSS pregnant patients.
From: A retrospective analysis on maternal and neonatal outcomes in pSS/AITD pregnancies
Baseline characteristics | pSS with AITD (n = 50) | pSS without AITD (n = 65) | P-values |
|---|---|---|---|
Age, years, mean ± SD | 36.36 ± 4.90 | 33.88 ± 1.77 | < 0.001 |
BMI, kg/m2, mean ± SD | 22.76 ± 4.82 | 19.19 ± 1.17 | < 0.001 |
pSS disease duration, months, median (IQR) | 12 (0, 24) | 14 (12,36) | < 0.001 |
Multiparous, cases (%) | 23 (46.0) | 21 (32.3) | 0.134 |
Number of children born, n (%) | |||
 0 | 23 (46.0) | 44 (67.7) | 0.009 |
 1 | 21 (42.0) | 20 (30.8) | |
 2 | 4 (8.0) | 1 (1.5) | |
 >2 | 2 (4.0) | 0 (0) | |
Incidence of adverse pregnancy history | 21 (42.0) | 27 (41.5) | 0.96 |
Treatment during pregnancy | |||
 Glucocorticoids, n (%) | 13 (26.0) | 18 (27.7) | 0.839 |
 Hydroxychloroquine, n (%) | 11 (22.0) | 15 (23.1) | 0.891 |
 Cyclosporin A, n (%) | 2 (4.0) | 4 (6.2) | 0.927 |
Laboratory test | |||
 ANA, n (%) | 39 (78.0) | 51 (78.5) | 0.953 |
 Anti-SSA, n (%) | 37 (74.0) | 50 (76.9) | 0.717 |
 Anti-SSB, n (%) | 18 (36.0) | 21 (32.3) | 0.678 |
